HCA Healthcare, Inc. HCA
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 78.70B | 78.01B | 76.39B | 75.60B | 74.37B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.70B | 78.01B | 76.39B | 75.60B | 74.37B |
| Cost of Revenue | 45.05B | 44.80B | 44.60B | 44.23B | 43.60B |
| Gross Profit | 33.65B | 33.22B | 31.79B | 31.37B | 30.77B |
| SG&A Expenses | 1.03B | 1.03B | 1.03B | 1.03B | 1.05B |
| Depreciation & Amortization | 3.74B | 3.67B | 3.59B | 3.52B | 3.47B |
| Other Operating Expenses | 16.83B | 16.44B | 15.19B | 14.86B | 14.62B |
| Total Operating Expenses | 66.65B | 65.94B | 64.42B | 63.64B | 62.74B |
| Operating Income | 12.05B | 12.07B | 11.97B | 11.97B | 11.63B |
| Income Before Tax | 9.82B | 9.87B | 9.79B | 9.83B | 9.29B |
| Income Tax Expenses | 2.02B | 2.02B | 1.98B | 2.05B | 1.99B |
| Earnings from Continuing Operations | 7.80K | 7.85K | 7.81K | 7.78K | 7.31K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.02B | -1.01B | -1.02B | -998.00M | -961.00M |
| Net Income | 6.78B | 6.84B | 6.79B | 6.78B | 6.34B |
| EBIT | 12.05B | 12.07B | 11.97B | 11.97B | 11.63B |
| EBITDA | 15.79B | 15.75B | 15.57B | 15.49B | 15.10B |
| EPS Basic | 30.45 | 30.14 | 29.35 | 28.63 | 26.12 |
| Normalized Basic EPS | 22.83 | 22.60 | 21.93 | 21.61 | 20.45 |
| EPS Diluted | 30.18 | 29.87 | 29.08 | 28.38 | 25.87 |
| Normalized Diluted EPS | 22.63 | 22.39 | 21.72 | 21.42 | 20.26 |
| Average Basic Shares Outstanding | 889.43M | 907.73M | 926.36M | 949.71M | 974.31M |
| Average Diluted Shares Outstanding | 897.40M | 916.37M | 935.45M | 958.24M | 982.84M |
| Dividend Per Share | 3.06 | 3.00 | 2.94 | 2.88 | 2.82 |
| Payout Ratio | 10.05% | 9.97% | 10.04% | 10.01% | 10.75% |